Early Stage Investment Forum 


Thursday 1 November

A key element of the AusBiotech 2018 conference is a one-day Early Stage Investment Forum featuring approximately 20 presentations from local research institutes, universities, hospitals and pre-series A companies in the area of human therapeutics and enabling technologies. The pitches will be made to an
expert investor panel that will include international big pharma representatives as well as corporate VCs
and early stage investors.


The forum will be open to AusBiotech attendees and will take place on Thursday 1 November at the AusBiotech 2018 national conference in Brisbane between 11.00am – 5.00pm.


Call for Submissions information


Applicants are invited to submit their interest to be considered for a presentation on the program. Submissions received will be reviewed by the appointed Advisory Group and applicants will be contacted with further information once the evaluation process is complete by mid-September.


Conditions and requirements:

  • Successful applicants will be required to present on Thursday 1 November between 11.00am – 5.00pm at the AusBiotech 2018 conference in Brisbane. Each accepted presentation will be allocated 2 free BioIndustry exhibition hall access passes for the AusBiotech 2018 conference for use on the day (please note travel and accommodation is at the presenters own expense);
  • Submissions are only open to investable projects from Australian research institutions or companies seeking seed or series A investment;
  • Information included in the application process and presented on the day should be  non-confidential;
  • Applications from Institutions with Technology Transfer or Research Commercialisation Offices must have prior approval from the relevant technology transfer or commercialisation office, unless the entire IP rights to the project have been assigned to the individual submitting the proposal;
  • Where relevant, applications are preferred from the associated technology transfer or commercialisation offices of the Institutions;
  • Companies seeking seed or series A investment and Institutions without technology transfer or commercialisation offices should apply directly;
  • Presenters will be allocated 7 minutes per presentation, with a further 5 minutes for Q&A from the investor panel;
  • Upon acceptance, a template will be provided for the presentation, with a limit of 5 slides (not including the title slide) per presentation. Use of the template will be strictly enforced.


Submission Process: Please download and complete the template and return to events@ausbiotech.org, with the email subject ‘Early Stage Investment Forum – <Project name> presentation submission’.  The application will be reviewed by the Early Stage Investment Forum Advisory Group and applicants will be contacted by mid-September to indicate if they have been successful and will be invited to present on the day.


Deadline: submissions must be received by no later than 10 September 2018 (extended from the 31 August)


Contact: For further information, please contact events@ausbiotech.org or +613 9828 1400.